Momentum

Relative Strength (%)
1m-13.19%
3m
6m
1yr
Volume Change (%)
10d/3m
Price vs... (%)
52w High-85.7%
50d MA
200d MA

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 201231st Dec 2013
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2012 / 2013

Blurred out image of Viaderma EPS forecast chart

Profile Summary

ViaDerma, Inc. is a specialty pharmaceutical company. The Company, through its subsidiary, is mainly engaged in the manufacture and sales of pharmaceutical related products in the United States of America. Its lead product, topical antibiotic is sells under the brand name Vitastem. The Company also has products in development in the fields include anti-aging skin care, pain management, hair-loss, and toenail fungus. The Company is in the early development stage of a medical cannabis product containing cannabidiol (CBD). The Company’s products are sold to local medical practitioners, and patients in clinics primarily in the Los Angeles, California area. The Company's products are used within the over-the-counter (OTC) drug market.

Directors

Last Annual
December 31st, 2011
Last Interim
June 30th, 2012
Incorporated
April 6th, 2010
Public Since
June 10th, 2008
No. of Shareholders
87
No. of Employees
75
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
983,556,451

VDRM Share Price Performance

FAQ

Or unlock with your email

Or unlock with your email